BILL ANALYSIS Ó SCR 162 Page 1 Date of Hearing: August 29, 2016 ASSEMBLY COMMITTEE ON RULES Richard S. Gordon, Chair SCR 162 (Fuller) - As Introduced August 3, 2016 SENATE VOTE: 36-0 SUBJECT: Adrenoleukodystrophy Awareness Month SUMMARY: Memorializes the month of November 2016 as Adrenoleukodystrophy Awareness Month. Specifically, this resolution makes the following legislative findings: 1.X-linked adrenoleukodystrophy (X-ALD) is one of a group of genetic disorders called the leukodystrophies that cause damage to the myelin sheath, an insulating membrane that surrounds nerve cells in the brain. 2.Women have two X chromosomes and are the carriers of the disease, but men are most severely affected because men only have one X chromosome and lack the protection provided by an extra X chromosome. 3.X-ALD affects an estimated one in every 20,000 boys, which is roughly 13,600 people in the United States, including boys like Jeremy Hill Jr. of Bakersfield. 4.The most common symptoms are behavioral changes, including abnormal withdrawal or aggression, poor memory, and poor school performance. Other symptoms include visual loss, learning disabilities, seizures, poorly articulated speech, SCR 162 Page 2 difficulty swallowing, deafness, disturbances of gait and coordination, fatigue, intermittent vomiting, increased skin pigmentation, and progressive dementia. 5.Newborn screening is effective in catching and preventing the negative effects of X-ALD and is relatively inexpensive. 6.The prognosis for patients with childhood cerebral X-ALD is generally poor due to progressive neurological deterioration, unless bone marrow transplantation is performed early. Death usually occurs between one and 10 years after the onset of symptoms of childhood cerebral X-ALD. 7.Recent evidence suggests that a mixture of oleic acid and erucic acid, known as "Lorenzo's Oil," administered to boys with X-ALD prior to the onset of symptoms can prevent or delay, but not stop, the appearance of the childhood cerebral form of X-ALD. FISCAL EFFECT: None REGISTERED SUPPORT / OPPOSITION: Support None on file Opposition None on file Analysis Prepared by:Nicole Willis / RLS. / (916) 319-2800 SCR 162 Page 3